Drug and nucleic acid delivery and targeting to the brain

Affiliations

¹ Department of Pharmacy, Birla Institute of Technology and Science Pilani, Vidya Vihar, Pilani, Rajasthan 333031, India. Electronic address: deepak.chitkara@pilani.bits-pilani.ac.in.
² Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Editorial

Deepak Chitkara et al. J Control Release. 2024 May.

. 2024 May:369:684-686.

doi: 10.1016/j.jconrel.2023.09.046. Epub 2024 Apr 12.

¹ Department of Pharmacy, Birla Institute of Technology and Science Pilani, Vidya Vihar, Pilani, Rajasthan 333031, India. Electronic address: deepak.chitkara@pilani.bits-pilani.ac.in.
² Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.

No abstract available

References

1. Sethi B, Kumar V, Mahato K, Coulter DW, Mahato RI, Recent advances in drug delivery and targeting to the brain, J. Control. Release 350 (2022) 668–687, 10.1016/j.jconrel.2022.08.051. - DOI - PMC - PubMed
1. Qi D, Lin H, Hu B, Wei Y, A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells, J. Control. Release 358 (2023) 78–97, 10.1016/j.jconrel.2023.04.020. - DOI - PubMed
1. Janjua TI, Cao Y, Ahmed-Cox A, Raza A, Moniruzzaman M, Akhter DT, Fletcher NL, Kavallaris M, Thurecht KJ, Popat A, Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma, J. Control. Release 357 (2023) 161–174, 10.1016/j.jconrel.2023.03.040. - DOI - PubMed
1. Chen J, Yuan M, Madison CA, Eitan S, Wang Y, Blood-brain barrier crossing using magnetic stimulated nanoparticles, J. Control. Release 345 (2022) 557–571, 10.1016/j.jconrel.2022.03.007. - DOI - PubMed
1. Solomon M, Loeck M, Silva-Abreu M, Moscoso R, Bautista R, Vigo M, Muro S, Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases, J. Control. Release 349 (2022) 1031–1044, 10.1016/j.jconrel.2022.07.022. - DOI - PMC - PubMed